5 Best Prefered Stocks For 2016

5 Best Prefered Stocks For 2016: Amedisys Inc(AMED)

Amedisys, Inc., a health care company, provides home health and hospice services primarily in the United States. It operates in two segments, Home Health and Hospice. The Home Health segment offers various services in the homes of individuals who may be recovering from an illness, injury, or surgical procedure. This segment?s services include skilled nursing, home health aides, physical and occupational therapy, speech therapy, and medical social services; and chronic care clinical programs for patients with chronic diseases, such as cardiovascular, respiratory, diabetes, behavioral health, rehabilitative, and medical surgical conditions. The Hospice segment provides care that is designed to offer comfort and support for those who are facing a terminal illness, such as heart disease, pulmonary disease, dementia, Alzheimer?s, HIV/AIDS, or cancer. As of December 31, 2011, the company owned and operated 440 Medicare-certified home health care centers, 87 Medicare-certified ho spice care centers, and 2 hospice inpatient units in 41 states within the United States, the District of Columbia, and Puerto Rico. Amedisys, Inc. was founded in 1982 and is headquartered in Baton Rouge, Louisiana.

Advisors' Opinion:

• [By Roberto Pedone]

  Another stock that looks poised to trigger a big breakout trade is Amedisys (AMED), which is engaged in delivering personalized health care services to patients and their families. This stock has been on fire so far in 2013, with shares up a whopping 61%.

  If you look at the chart for Amedisys, you'll notice that this stock has been trending sideways inside of a consolidation chart pattern right above its 50-day moving average at $16.92, with shares moving between $16.04 on the downside and $18.70 on the upside. Shares of AMED are now starting to spike higher right above its 50-day, and it's quickly moving within range of triggering a big breakout trade above the upper-end of its! recent range.

  Traders should now look for long-biased trades in AMED if it manages to break out above some near-term overhead resistance levels at $18.05 to its 52-week high at $18.70 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 444,954 shares. If that breakout triggers soon, then AMED will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $25 to $27 a share.

  Traders can look to buy AMED off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $16.92 a share or below more near-term support at $16.62 a share. One can also buy AMED off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

• [By Sean Williams]

  Last week, we saw home-health sector stocks like Amedisys (NASDAQ: AMED  ) and Gentiva Health Solutions (NASDAQ: GTIV  ) get clobbered because the Centers for Medicare and Medicaid Services recommended a 1.5% reduction in Medicare reimbursements each year between 2014 and 2017. With Amedisys and Gentiva reliant on Medicare for more than 80% and 90% of their revenue, respectively, it could put hospitals that rely on government reimbursements in a growth bind.

• [By Brendan Conway]

  That zipping sound you hear is home-health providerAmedisys‘ (AMED) 24% surge on news thatprivate-equity giant Kohlberg Kravis Roberts & Co.has a stake of more than 8% in the stock.

  CRT Capital analyst Sheryl Skolnick, a critic of company management, upgrades to “fair value” this morning and essentially tells clients to get out of KKR’s way, since the firm could end up ushering in a new board and management:

  There are times when this analyst will ‘take on’ sharehold! ers with ! differing views and there are times when she knows, from long experience, not to even think about it. This is one of the latter times ….

  We know that when activists get involved, strange and interesting things happen, even (especially?) with entrenched managements. For the record, we think it unlikely that this part of KKR will take AMED private: filing a 13-D that almost surely takes the stock up would be that act of amateurs, in our view, not the act of a savvy firm like KKR. Some may conclude from the language of the 13-D that KKR may not actually become active. We reviewed it and found it nearly identical to other activists’ initial statements: then things changed. Thus, a new Board and management does seem likely and is indeed the strategy we advocated in our 4/3/13 report and THAT is the root cause of our upgrade.

  But for the 13-D we would NOT have upgraded. Indeed, we were in the midst of preparing a strong reiteration of our view that AMED cannot be fixed by this CEO and his Board. We reiterate that view here and strongly suspect that any activist likely has or will reach that same conclusion.

• [By Sean Williams]

  What: Shares of home health providers Amedisys (NASDAQ: AMED  ) , Gentiva Health Services (NASDAQ: GTIV  ) , andLHC Group (NASDAQ: LHCG  ) swooned as much as 28%, 20%, and 15%, respectively, following a public proposal by the Centers for Medicare and Medicaid Services, or CMS, late yesterday that in-home health care reimbursements be cut by 1.5% in 2014.

source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/5-best-prefered-stocks-for-2016.html

Morgan Stanley nabs $1.5B J.P. Morgan team

Bloomberg

Morgan Stanley has landed a $1.5 billion team from J.P. Morgan Securities LLC in the latest in a series of high-profile, late-summer acquisitions.

Scott Siegel, a Barron's top 1,000 adviser, and his team of Mehmet Kirdar, Michael O'Hara and Joseph Carmody, have joined Morgan Stanley's New York City office, the company announced Tuesday.

The team moved last Friday from J.P. Morgan, with the exception of Mr. Carmody, who was recruited from UBS Financial Services Inc.

Known as the SKOC team at Morgan Stanley, the group has $6.1 million of trailing 12-month production, according to the firm.

Doug Morris, a J.P. Morgan spokesman, declined to comment.

Mr. Siegel and his branch manager, Michael Simeone, were not immediately available Tuesday.

A March Barron's profile said Mr. Siegel manages balanced portfolios and favors high-yield bonds of five to eight years, together with dividend and value stocks.

Last Friday, Morgan Stanley landed Atlanta-based Jason Moss, a former Bank of America Merrill Lynch broker with $130 million in assets, in addition to the Coral Gables, Fla., team of Al Maulini and Joseph Torano, who managed $121 million at HSBC Securities Inc.

Last Thursday, Morgan picked up brothers Frank and Donald Marano from Raymond James Financial Services Inc. The Allentown, Pa., duo manages $100 million.

Opening Print and S&P Levels to Watch

The Asian markets closed lower (Shanghai Comp. -2.05%) and Europe is trading modestly lower. Today is the first day of the long-awaited two-day Federal Open Market Committee meeting. While today will be prone to headline news, the real headlines do not start until Wednesday's FOMC meeting announcement, with forecasts at 1:00 CT and the Bernanke press conference at 1:30. We were right about selling the early rally and a low-volume grind, but this time it was a downward grind. Don't listen to anyone; the real reason the ESZ (S&P e-mini futures) sold off was simple. All the buying associated with Larry Summers headlines was done Sunday night into Monday morning. By the time the S&P futures opened at 8:30 CT the buying was used up and what was left was all sell stops and sell programs. It was definitely a case of selling the news. One by one the S&P is knocking down all the upside obstacles and making bad news into good. That is how it works. It's not just picking levels on your charts to buy and sell at. Learning the feel of the S&P can be just as important as a critical support or resistance level. Just two weeks ago the markets were worried about the Fed taper and Syria, and now the S&P has seen its largest weekly gain in eight months. There is definitely a psychological side to the markets at work. Our view: The S&P has closed higher 8 out of the first 10 trading days of September for a total gain of 66.5 handles and has rallied 78.75 handles from its 1625.00 low. It has been a nonstop buy fest, but it's all short covering. Based on that price action, one would think there is probably more selling around for today. We again lean to selling the early rally and buying weakness. The S&P futures may not close above the contract highs today, but we can't rule out that possibility on Wednesday afternoon. There is a congestion of buy stops building up above 1704 vs. the Dec e-mini S&P that runs to the 1712-1715 level. As always, use stops and keep an eye on the 10-handle rule. Don't forget to catch MrTopStep on The Closing Print video found under the OptionsTV page (top bar) on Options Profits. We report directly from the SPX pits, wrapping up the day and positioning for trade tomorrow. OptionsProfits can be followed on Twitter at twitter.com/OptionsProfits MrTopStep can be followed on Twitter at twitter.com/MrTopStep For LIVE futures chat, more information on the 10-handle rule and futures educational content CLICK HERE FOR A SEVEN-DAY FREE TRIAL.

10 Best Consumer Stocks To Own For 2015

SAN FRANCISCO -- Can the rise of crowdfunding bring money pooling to the masses?

With an explosion of consumer electronics, food trucks and art projects financed by crowds of individuals online, crowdfunding is in a boom. Startup Crowdtilt wants to make crowdfunding popular for everyday activities -- such as group-funded parties, trips or gifts -- and plans to take the business worldwide.

"It's typically really hard for a group to pool resources. It will resonate with people for smaller bite-sized campaigns," says Crowdtilt CEO and co-founder James Beshara.

The Startup, based here, today announced a $23 million second round of funding led by Andreessen Horowitz that includes SV Angel, Sean Parker and Silicon Valley Bank. Crowdtilt plans to use the investment to hire employees and stake out its international expansion.

5 Best Restaurant Stocks To Own Right Now: Spectrum Brands Holdings Inc.(SPB)

Spectrum Brands Holdings, Inc., together with its subsidiaries, operates as a consumer products company worldwide. It offers consumer batteries, including alkaline and zinc carbon batteries, rechargeable batteries and chargers, and hearing aid batteries and other specialty batteries; pet supplies, such as aquatic equipment and supplies, dog and cat treats, small animal foods, clean up and training aids, health and grooming products, and beddings; and home and garden control products comprising household insect controls, insect repellents, and herbicides. The company also provides electric shaving and grooming devices; small appliances, including small kitchen appliances and home product appliances; electric personal care and styling devices; and portable lighting. Its sells its products through various trade channels, including retailers, wholesalers and distributors, hearing aid professionals, industrial distributors, and original equipment manufacturers primarily under t he Rayovac, Remington, Varta, George Foreman, Black & Decker, Toastmaster, Farberware, Tetra, Marineland, Nature?s Miracle, Dingo, 8-in-1, Littermaid, Spectracide, Cutter, Repel, Hot Shot, Black Flag, and TAT brands. The company was headquartered in Madison, Wisconsin. As of January 7, 2011, Spectrum Brands Holdings, Inc. operates as a subsidiary of Harbinger Group Inc.

Advisors' Opinion:

• [By Marc Bastow]

  Consumer products manufacturer Spectrum Brands (SPB) raised its quarterly dividend 20% to 30 cents per share, payable on Mar. 18 to shareholders of record as of Feb. 19.
  SPB Dividend Yield: 1.58%

• [By Ben Levisohn]

  Shares of Energizer have jumped 15% to $112.37 at 10:24 a.m. today, while Spectrum Brands (SPB) has risen 1.4% to $76.88 and Kimberly Clark (KMB) has gained 1% to $112.14.

10 Best Consumer Stocks To Own For 2015: Tootsie Roll Industries Inc.(TR)

Tootsie Roll Industries, Inc. engages in the manufacture and sale of confectionery products primarily in the United States, Canada, and Mexico. The company sells its products under the TOOTSIE ROLL, TOOTSIE ROLL POPS, CHILD?S PLAY, CARAMEL APPLE POPS, CHARMS, BLOW-POP, BLUE RAZZ, ZIP-A-DEE POPS, CELLA?S, MASON DOTS, MASON CROWS, JUNIOR MINT, CHARLESTON CHEW, SUGAR DADDY, SUGAR BABIES, ANDES, FLUFFY STUFF, DUBBLE BUBBLE, RAZZLES, CRY BABY, and NIK-L-NIP. It distributes its products through candy and grocery brokers to the wholesale distributors of candy and groceries, supermarkets, variety stores, dollar stores, chain grocers, drug chains, discount chains, cooperative grocery associations, warehouse and membership club stores, vending machine operators, and the U. S. military and fund-raising charitable organizations. The company was founded in 1896 and is based in Chicago, Illinois.

Advisors' Opinion:

• [By Sean Williams]

  Leave the wrapper on
  The returns on confectioner Tootsie Roll Industries (NYSE: TR  ) have certainly been sweet for investors over the past year. You have to go back to the summer of 2010 to find sugar prices that were as low as they are now,�which has played a good part in helping Tootsie Roll keep that aspect of its costs down. But taking a bigger view of what's going on with Tootsie Roll and comparing that to its current valuation creates a sour taste in my mouth.

• [By Rich Smith]

  At the same time, tiny Tootsie Roll (NYSE: TR  ) may see its sales grow as little as 13% through 2016. Could it be that in the candy industry, bigger is better? Does Hershey lack the scale to compete effectively against mammoth Mondelez?

10 Best Consumer Stocks To Own For 2015: LendingClub Corp (LC)

LendingClub Corporation, incorporated on October 2, 2006, provides online marketplace connecting borrowers and investors. The Company operates an online market that connects borrowers looking for loans with individuals with the money to fund them. It lends money to help consumers pay off credit-card bills, consolidate debt and take vacations. Its platform enables customers in investing in and obtaining personal loans by providing financial data and credit information.

The Company provides search algorithm, credit decisioning, a secondary market, and a choice of loan durations. The Company serves the professional fixed income investors, such as family offices and insurance companies.

Advisors' Opinion:

• [By Rana Pritanjali]

  Lending Club's (NYSE: LC  ) stock is up a stellar 66% since the company went public in December. The peer-to-peer lending specialist offers an alternative to the traditional banking system with an online platform for borrowers and lenders. It has a leading 40% share of the�peer-to-peer lending market, far outstripping No. 2 player�Prosper.com and its 8% market share.�

10 Best Consumer Stocks To Own For 2015: Pazoo Inc (PZOO)

Pazoo, Inc., formerly IUCSS, Inc., incorporated on November 16, 2010, is a development-stage company. The Company is an online retailer and distributer of nutritional foods/supplements, wellness goods, and fitness apparel.

As of December 31, 2011, the Company�� source of revenue was through www.pazoo.com. The Company offers a range of products through various catalogs, such as health and beauty, vitamins and supplements, apparel, accessories, food and beverages, fitness and sports equipments, gifts, videos and books, and pet wellness.

Advisors' Opinion:

• [By Bryan Murphy]

  For those traders who were lucky and smart enough to be in an Arotech Corporation (NASDAQ:ARTX) before today, then congratulations - you're up at least 38% on your position. Now it's time to get out. Conversely, if you're looking for a new name to get into (or perhaps looking for a place to park your ARTX proceeds), then you may want to consider Pazoo Inc. (OTCBB:PZOO)... a tiny online retailer of health and fitness goods. PZOO has dropped several tell-tale hints that more upside is on the way.

10 Best Consumer Stocks To Own For 2015: Treehouse Foods Inc.(THS)

TreeHouse Foods, Inc. operates as a food manufacturer in the United States and Canada. The company?s products include non-dairy powdered creamers; private label canned soups; salad dressings and sauces; powdered drink mixes; and hot cereals, such as oatmeal, farina, and grits in single-serve instant packets and microwaveable bowls. It also offers macaroni and cheese; skillet dinners; Mexican and other sauces comprising salsa, picante, cheese dip, enchilada sauce, pasta sauce, and taco sauce; jams and pie fillings; pickles and related products, including peppers and pickled vegetables; aseptic products, such as cheese sauces and puddings; and refrigerated salad dressings and liquid non-dairy creamer products. The company offers pickles under the Farman?s, Nalley?s, Peter Piper, and Steinfeld brand names; sauces and syrups under the Bennett?s, Hoffman House, Roddenbery?s Northwoods, and San Antonio Farms brand names; non-dairy powdered creamer under the Cremora brand na me; refrigerated products under the Mocha Mix and Second Nature brand names; jams and other sauces under the E.D. Smith and Habitant brand name; oatmeal under the McCann?s brand name; and food away from home products under the Schwartz and Saucemaker brands. It primarily serves grocery retailers, mass merchandisers, and foodservice operators through various distribution channels, including retail grocery; foodservice distributors; and industrial and export channels comprising food manufacturers and repackagers of foodservice products. TreeHouse Foods, Inc. was founded in 1862 and is based in Oak Brook, Illinois.

Advisors' Opinion:

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Treehouse Foods (NYSE: THS  ) , whose recent revenue and earnings are plotted below.

• [By TaniaC]

  The consumer staples sector is facing several hiccups over the past few quarters as consumers are spending less and demand is declining. Investors can still expect a healthy return in this sector by investing in TreeHouse Foods Inc. (THS) as this player is playing well despite of all odds.

• [By Vinay Singh]

  On the other hand, food manufacturer TreeHouse Foods (THS) has witnessed higher demand for its products. Its fourth-quarter revenue surged 11.4% over last year as revenue clocked in at $660.3 million. The acquisitions of Cains Foods and Associated Brands last year and an increase in volumes drove this revenue gain. The company also recently acquired Associated Brands, which added to its private-label food product portfolio. Also, TreeHouse's launch of specialty teas enabled it to expand its single-serve coffee business. Hence, this company provides tough competition to other food players.

10 Best Consumer Stocks To Own For 2015: Panasonic Corp (PCRFF)

Panasonic Corporation is a Japan-based electronics manufacturer. The Audio-Visual Computer (AVC) Network segment offers audio and video equipment. The Appliance segment provides household air-conditioning machines. The System Communications segment provides system network and mobile communications-related products and services. The Eco-solutions segment consists of riding, energy system, housing system and others. The Automotive systems segment provides automotive multimedia-related equipment and others. The Device segment provides electronic components, semiconductors and optical devices. The Energy segment provides solar system and lithium-ion batteries. The Others segment consists of health care, manufacturing solutions and PanaHome. On October 1, 2013, it announced it had set up a research and development center in Singapore. In December 2013, it transferred its 66.7% stake in a Japan-based subsidiary. In December 2013, it acquired a Turkey-based company. Advisors' Opinion:

• [By MARKETWATCH]

  LOS ANGELES (MarketWatch) -- Japanese stocks slipped early Monday, with the Nikkei Stock Average (JP:NIK) down 0.1% at 14,298.17, and the Topix dropping 0.4%. Singapore-traded lead futures for the Nikkei Average had suggested a 0.8% gain for the index, but the indicator fell after the Cabinet Office reported fourth-quarter economic growth of 0.3%, flat from the previous quarter and below expectations in separate Reuters and Wall Street Journal/Nikkei surveys. The disappointing economic data also pushed the yen higher, weighing on some exporters, with Panasonic Corp. (JP:6752) (PCRFF) down 1.8%, NEC Corp. (JP:6701) (NIPNF) off 1.3%, and Sony Corp. (JP:6758) (SNE) down 0.7% after S&P downgraded the firm's credit rating to BBB- from BBB with a negative outlook. Shares of Internet retailer Rakuten Inc. (JP:4755) (RKUNF) dropped 12% after announcing plans to buy online messaging and telecom firm Viber Media Inc. for $900 million as well as posting below-consensus full-year profit. Banks were broadly lower, with Mizuho Financial Group Inc. (JP:8411) (MFG) off 1% and Sumitomo Mitsui Financial Group Inc. (JP:8316) (SMFG) off 1.1%, though Daiwa Securities Group Inc. (JP:8601)

• [By MARKETWATCH]

  LOS ANGELES (MarketWatch) -- A rising Japanese yen and weak results from Caterpillar Inc. (CAT) overnight sent Tokyo-listed shares lower in early Thursday trade, with the Nikkei Stock Average (JP:NIK) falling 0.4% to 14,363.59, while the Topix also lost 0.4%. With the U.S. dollar remaining below the 98-yen level amid concerns about the health of China's largest banks, some currency-sensitive shares extended their losses after driving the Nikkei Average down 2% in the previous session. Among them, trading house Mitsui & Co. (JP:8031) (MITSY) fell 1.3%, retail major J. Front Retailing Co. (JP:3086) lost 1.2%, auto maker Nissan Motor Co. (JP:7201) (NSANY) retreated 0.6%, and Fujitsu Ltd. (JP:6702) (FJTSY) traded 1% lower. The below-forecast quarterly results and outlook cut from U.S. construction-equipment maker Caterpillar sent its Japanese rivals tumbling, with Komatsu Ltd. (JP:6301) (KMTUF) dropping 3.5% and Hitachi Construction Macheriny Co. (JP:6305) (HTCMF) falling 3.1%. On the upside, Hitachi Ltd. (JP:6501) (HTHIF) soared 5.4% after raising its profit and revenue guidance for the fiscal first hal

• [By Melvin Backman]

  Tesla hopes the Model 3 will cost between $30,000 to $40,000. The flagship Model S costs nearly $70,000 and Tesla's upcoming crossover, the Model X, will cost about that much. Panasonic (PCRFF) will partner with Tesla on the Gigafactory, which broke ground in July.

10 Best Consumer Stocks To Own For 2015: Fomento Economico Mexicano SAB de CV (FOMC)

Fomento Economico Mexicano SAB de CV (FEMSA) is a Mexico-based holding company engaged in the beverages industry. Through its subsidiary Coca-Cola FEMSA SAB de CV, the Company is active in the production and distribution of a variety of non-alcoholic beverages, bottled water and still beverages such brands as Coca-Cola, Fanta, Sprite, Powerade, Delaware Punch and other trademark beverages of The Coca-Cola Company in Mexico. Through FEMSA Comercio SA de CV, it operates the OXXO convenience-store chain in Latin America. The Company operates in a number of Latinamerican countries and in Philippines. Advisors' Opinion:

• [By Canadian Value]

  Also interesting is that the duration of rising rate environments is distinctly shorter after 1982. The average duration declines to 14 months from 40 months prior to 1982. A possible explanation could be changes in the monetary mechanism influencing interest rates. In 1982, the Federal Open Market Committee (FOMC) first referenced a targeted federal funds rate.7

• [By CanadianValue]

  Former Philadelphia Fed President Edward Boehne elegantly described the approach at a Federal Open Market Committee (FOMC) meeting in late 1989:

  ��ow, sooner or later, we will have a recession. I don�� think anybody around the table wants a recession or is seeking one, but sooner or later we will have one. If in that recession we took advantage of the anti-inflation (impetus) and we got inflation down from 4 1/2 percent to 3 percent, and then in the next expansion we were able to keep inflation from accelerating, sooner or later there will be another recession out there. And so, if we could bring inflation down from cycle to cycle just as we let it build up from cycle to cycle, that would be considerable progress over what we��e done in other periods in history.��/p>

4 Biotech Stocks Under $10 Making Big Moves

DELAFIELD, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.

Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside today.

Amarin

Amarin (AMRN) is a biopharmaceutical company that commercializes and develops therapeutics to improve cardiovascular health. This stock closed up 6% to $5.62 in Tuesday's trading session.

Tuesday's Range: $5.39-$5.70

52-Week Range: $5.12-$14.97

Tuesday's Volume: 9.30 million

Three-Month Average Volume: 3.74 million

Shares of AMRN ripped higher on Tuesday after H.C. Wainwright upgraded the stock.

From a technical perspective, AMRN gapped up sharply here and broke out above some near-term overhead resistance at $5.59 with monster upside volume. This stock has been downtrending badly for the last six months, with shares dropping from over $8 to its recent low of $5.12. During that move, shares of AMRN have been consistently making lower highs and lower lows, which is bearish technical price action. That said, shares of AMRN have now started to rebound off that $5.12 low and are quickly moving within range of triggering a major breakout trade. That trade will hit if AMRN manages to take out some near-term overhead resistance levels at $5.74 to its 50-day at $5.88 and then once it takes out more resistance at $6.20 with high volume.

Traders should now look for long-biased trades in AMRN as long as it's trending above some key near-term support levels at $5.13 to $5.12, and then once it sustains a move or close above those breakout levels with volume that hits near or above 3.74 million shares. If that breakout hits soon, then AMRN will set up to re-test or possibly take out its next major overhead resistance levels at $7.17 to $7.30. Any high-volume move above those levels will then put $8 to $8.50 within range for shares of AMRN.

Best Electric Utility Stocks To Invest In 2015

Coronado Biosciences

Coronado Biosciences (CNDO), a clinical stage biopharmaceutical company, focuses on the development of immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. This stock closed up 2.7% to $9.13 in Tuesday's trading session.

Tuesday's Range: $8.85-$9.58

52-Week Range: $4.00-$12.70

Tuesday's Volume: 1.31 million

Three-Month Average Volume: 419,038

From a technical perspective, CNDO trended up here right above some near-term support at $8.79 with heavy upside volume. This move is starting to push shares of CNDO within range of triggering a near-term breakout trade. That trade will hit if CNDO manages to take out some near-term overhead resistance levels at $9.60 to $10.20 and then once it takes out more resistance at $10.35 with high volume.

Traders should now look for long-biased trades in CNDO as long as it's trending above its 50-day at $8.52 and then once it sustains a move or close above those breakout levels with volume that hits near or above 419,038 shares. If that breakout hits soon, then CNDO will set up to re-test or possibly take out its next major overhead resistance levels at $11 to $11.81. Any high-volume move above those levels will then put its all-time high at $12.70 into range for shares of CNDO.

Vical

Vical (VICL) engages in the research and development of biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. This stock closed up 5.8% to $1.62 in Tuesday's trading session.

Tuesday's Range: $1.53-$1.63

52-Week Range: $1.37-$4.74

Tuesday's Volume: 7.28 million

Three-Month Average Volume: 1.53 million

From a technical perspective, VICL bounced higher here right above its recent 52-week low at $1.37 with monster upside volume. This stock recently gapped down big from $3.75 to $1.37 with huge downside volume. That move has now pushed shares of VICL into extremely oversold territory, since its current relative strength index reading is 21.80. Oversold can always get more oversold, but it's also an area where a stock can experience a powerful bounce higher from.

Traders should now look for long-biased trades in VICL as long as it's trending above its 52-week low at $1.37 and then once it sustains a move or close above Tuesday's high of $1.63 with volume that hits near or above 1.53 million shares. If we get that move soon, then VICL will set up to re-fill some of its previous gap down zone that started at $3.75. Some possible upside targets if VICL gets into that gap with volume are $2.25 to $2.50.

Siga Technologies

Siga Technologies (SIGA), a biopharmaceutical company, is engaged in the design, discovery and development of NNR Therapeutics, a new class of drugs for the treatment of diseases and disorders of the central nervous system. This stock closed up 1.7% to $3.56 in Tuesday's trading session.

Tuesday's Range: $3.50-$3.59

52-Week Range: $2.33-$4.60

Thursday's Volume: 88,000

Three-Month Average Volume: 270,742

From a technical perspective, SIGA bounced modestly higher here right above some near-term support at $3.32 with lighter-than-average volume. This bounce is starting to push shares of SIGA within range of triggering a big breakout trade. That trade will hit if SIGA manages to take out some near-term overhead resistance levels at $3.74 to $4 with high volume.

Traders should now look for long-biased trades in SIGA as long as it's trending above support at $3.32 or above its 50-day at $3.20 and then once it sustains a move or close above those breakout levels with volume that hits near or above 270,742 shares. If that breakout triggers soon, then SIGA will set up to re-test or possibly take out its next major overhead resistance levels at $4.43 to its 52-week high at $4.60. Any high-volume move above $4.60 will then put $5.50 to $6 within range for shares of SIGA.

To see more stocks that are making notable moves higher today, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr.

-- Written by Roberto Pedone in Delafield, Wis.